ATLAS fair value
NT$184.25
Below fair value · 55% discount
Grape King Bio stock price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · Taiwan Stock Exchange · Taiwan
Prices as of Oct 27, 2026 · TWD
NT$184.25
Below fair value · 55% discount
55%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Grape King Bio's fair value at about NT$184.25 per share (reasonable range: NT$154.12 to NT$260.42). At NT$83.80, the stock trades 55% below it.
It is calculated with a blend of a discounted cash-flow model and peer valuation multiples. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Grape King Bio a 55% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between NT$82.04 and NT$86.44; in 9 out of 10, between NT$78.32 and NT$90.54. Estimated annual volatility is 15%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Grape King Bio sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks 1707.TW has traded between NT$83.50 and NT$130.00. Today it is 35.5% below that high and 0% above its low.
On the business: net margin is 11.3%; it trades at 11.1 times earnings.
Its beta is 0.23: it tends to move less than the market.
Grape King Bio Ltd, together with its subsidiaries, produces and sells pharmaceutical preparations, patent medicines, liquid tonics, drinks, and healthy food in Taiwan, China, and internationally.
Want to see everything about Grape King Bio?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About NT$184.25 per share according to ATLAS (reasonable range: NT$154.12 to NT$260.42). With the stock at NT$83.80, it is 55% below it.
55%: close to a coin flip. In half of the simulated outcomes, 1707.TW ends the month between NT$82.04 and NT$86.44.
Grape King Bio's market capitalization is NT$13.0B. Its price-to-earnings (P/E) ratio is 11.1: you pay NT$11.1 for each NT$1.00 of yearly earnings.
Yes. 1707.TW's current dividend yield is 7.01% at today's price (NT$83.80).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy